Insider transactions

EDGAR

Polaryx Therapeutics, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-20.

Open-market purchases (code P)
2 transactions, 91,320 shares
Sum of shares × price per share: 367,994.3257
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–2 of 2

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-05-27 Filed 2026-05-28Yang Alex Keun Mo Director · Officer: Chief Executive Officer · 10% ownerMstone Partners Healthcare Ltd Director · 10% owner
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)88,4534.07
360,003.71

Derived: shares × price per share. Exact value 360003.71.

24,233,249Indirect (I) By Mstone Partners Healthcare LimitedNo
F1, F2
  • F1 As disclosed in the Issuer's Form 8-K filed with the Securities and Exchange Commission on May 28, 2026, MStone Partners Healthcare Limited (Mstone) purchased 88,453 shares of common stock in a private placement transaction, for gross proceeds to the Issuer of $360,000.
  • F2 Alex Keun Mo Yang is the founder and Chief Executive Officer of Mstone. Mr. Yang disclaims beneficial ownership over any of the reported securities, except to the extent of his pecuniary interest therein.
Open filing 0001213900-26-062322 Read from the filing’s XML Dispute this row
2026-02-18 Filed 2026-02-20Landis G. Michael Director · Officer: Chief Financial Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)2,8672.7871
7,990.6157

Derived: shares × price per share. Exact value 7990.6157.

228,225Direct (D) No— Open filing 0001213900-26-018845 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,925 filings read, the latest filed 2026-11-19. Prior quarter ending 2026-06-30: 9,176 filings read.

Showing 1–13 of 13

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
VANGUARD CAPITAL MANAGEMENT LLC 1,655,833 SH3,427,574 dollarsLower by 2,039 Prior quarter: 1,657,872Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager138,757 SH287,406 dollarsLower by 32,241 Prior quarter: 170,998Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
VANGUARD FIDUCIARY TRUST CO 80,320 SH166,262 dollarsLower by 24,752 Prior quarter: 105,072Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
STATE STREET CORP Partly reported under another manager68,004 SH140,768 dollarsHigher by 9,900 Prior quarter: 58,104Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
BlackRock, Inc. Partly reported under another manager41,012 SH84,895 dollarsUnchanged Prior quarter: 41,012Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
HRT FINANCIAL LP 33,103 SH68 dollarsLower by 48,991 Prior quarter: 82,094Open filing 0001475597-26-000249 Filed 2026-11-13 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager27,987 SH57,933 dollarsUnchanged Prior quarter: 27,987Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
Cerity Partners LLC 10,427 SH21,584 dollarsNot in the prior quarter’s filings read Open filing 0001172661-26-005020 Filed 2026-11-13 Dispute this row
Allworth Financial LP 7,727 SH15,995 dollarsUnchanged Prior quarter: 7,727Open filing 0001140361-26-044466 Filed 2026-11-17 Dispute this row
Vanguard Global Advisers, LLC 6,318 SH13,078 dollarsUnchanged Prior quarter: 6,318Open filing 0001811242-26-000017 Filed 2026-11-13 Dispute this row
UBS Group AG Partly reported under another manager4,355 SH9,015 dollarsHigher by 3,072 Prior quarter: 1,283Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
Tower Research Capital LLC (TRC) Partly reported under another manager1,855 SH3,840 dollarsLower by 1,147 Prior quarter: 3,002Open filing 0001533421-26-000010 Filed 2026-11-16 Dispute this row
BARCLAYS PLC Partly reported under another manager9 SH19 dollarsNot in the prior quarter’s filings read Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • JANE STREET GROUP, LLC 31,441 SH
  • Fortitude Family Office, LLC 189 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Mstone Partners Healthcare Limited Common stock, par value $0.0001 per share ("Common Stock")47.422,452,954.0001/29/2026 Filed 2026-02-05SCHEDULE 13DOpen filing 0001213900-26-012759 Dispute this row
MBstone Biotech Flagship Limited Common stock, par value $0.0001 per share ("Common Stock")0.4183,560.0001/29/2026 Filed 2026-02-05SCHEDULE 13DOpen filing 0001213900-26-012759 Dispute this row
Mstone Pediaorphan Singapore I Pte. Limited Common stock, par value $0.0001 per share ("Common Stock")0.2108,282.0001/29/2026 Filed 2026-02-05SCHEDULE 13DOpen filing 0001213900-26-012759 Dispute this row
Alex Keun Mo Yang Common stock, par value $0.0001 per share ("Common Stock")48.022,744,796.0001/29/2026 Filed 2026-02-05SCHEDULE 13DOpen filing 0001213900-26-012759 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,592,621 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201517,857
2016222,642
2017222,009
2018223,345
2019216,482
2020218,850
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026262,467

Filings made before the SEC required XML are listed, not extracted.

Back to Polaryx Therapeutics, Inc.